Adipotide Certificate of Analysis (COA) Standards

In preclinical laboratory investigation, ensuring exact chemical composition and structural integrity is paramount for reproducible experimental outcomes. This document outlines the analytical standards required for an Adipotide Certificate of Analysis (COA), detailing the high-performance liquid chromatography, mass spectrometry, and endotoxin metrics essential for rigorous in vitro and animal research protocols.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

In preclinical laboratory investigation, ensuring exact chemical composition and structural integrity is paramount for reproducible experimental outcomes. This document outlines the analytical standards required for an Adipotide Certificate of Analysis (COA), detailing the high-performance liquid chromatography, mass spectrometry, and endotoxin metrics essential for rigorous in vitro and animal research protocols.

Reviewed by PX1 Research scientific team

Key takeaways

  • Adipotide, also designated in scientific literature as FTPP or CKGGRAKDC-GG-D(KLAKLAK)2, is a synthetic peptidomimetic engineered to target specific vascular homing domains in white adipose tissue during preclinical investigations.
  • A rigorous [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) serves as a definitive quality assurance document generated by an accredited, independent analytical laboratory.
  • High-Performance Liquid Chromatography (HPLC), specifically reverse-phase HPLC (RP-HPLC), represents the gold standard technique for determining the chemical purity of synthetic peptides.
  • While HPLC quantifies purity by separating chemical species, Mass Spectrometry (MS) confirms the precise identity of the primary chromatographic peak.

Introduction to Adipotide (FTPP) and Preclinical Quality Requirements

Adipotide, also designated in scientific literature as FTPP or CKGGRAKDC-GG-D(KLAKLAK)2, is a synthetic peptidomimetic engineered to target specific vascular homing domains in white adipose tissue during preclinical investigations. The compound operates via a dual-domain structure: a targeting peptide sequence that binds to prohibitin expressed on the luminal surface of vascular endothelial cells, conjugated to a pro-apoptotic peptide motif that disrupts mitochondrial membranes upon internalization. Because small structural variations or truncation sequence contaminants can alter binding affinity or compromise apoptotic cascade activity, access to a lot-specific Adipotide research product with validated documentation is critical for laboratory investigators.

To maintain consistency across cell-based assays and rodent model studies, research facilities rely on comprehensive analytical verification. A legitimate Certificate of Analysis (COA) provides an empirical record of material purity, identity, and biological safety limits, ensuring that experimental variables stem solely from the experimental design rather than compound impurities or degraded fragments.

Key Analytical Components of a Legitimate Peptide COA

A rigorous Certificate of Analysis serves as a definitive quality assurance document generated by an accredited, independent analytical laboratory. Rather than relying on generic batch specifications, each synthesized lot of Adipotide must undergo individual testing prior to release for laboratory distribution. Evaluating these parameters requires familiarity with standard analytical methodology used in synthetic peptide chemistry.

For a full overview of documentation standards across our catalog, investigators can reference our comprehensive peptide COA standards overview. In summary, a standard laboratory-grade COA for Adipotide must explicitly detail five essential analytical parameters: High-Performance Liquid Chromatography (HPLC) purity percentage, Mass Spectrometry (MS) mass-to-charge confirmation, bacterial endotoxin content quantification, physical appearance assessment, and residual moisture level analysis.

High-Performance Liquid Chromatography (HPLC) Purity Verification

High-Performance Liquid Chromatography (HPLC), specifically reverse-phase HPLC (RP-HPLC), represents the gold standard technique for determining the chemical purity of synthetic peptides. During RP-HPLC analysis, the Adipotide sample is dissolved in an appropriate mobile phase and passed through a non-polar stationary phase column under high pressure. Peptide molecules and synthesis byproducts separate based on hydrophobic interactions, eluting at specific retention times.

The resulting chromatogram displays distinct peaks corresponding to the target molecule and any trace impurities, such as deletion sequences, incomplete coupling products, or oxidation derivatives. The area under the primary peak relative to the total peak area yields the percentage purity. For high-fidelity preclinical research, PX1 Research enforces a minimum threshold of ≥98.0% HPLC purity for every lot, ensuring that target receptor interactions in vitro are not confounded by peptide synthesis artifacts.

Mass Spectrometry (MS) Confirmation of Chemical Identity

While HPLC quantifies purity by separating chemical species, Mass Spectrometry (MS) confirms the precise identity of the primary chromatographic peak. Liquid Chromatography-Mass Spectrometry (LC-MS) or Electrospray Ionization Mass Spectrometry (ESI-MS) measures the mass-to-charge ratio ($m/z$) of ionized Adipotide fragments to verify that the molecular weight matches theoretical calculations precisely.

Adipotide has a theoretical monoisotopic molecular weight of approximately 2555.1 Da (varying slightly based on specific salt formulations or terminal modifications). The MS spectrum included on the COA displays the parent ion peak, typically observed as double or triple charged ions ($[M+2H]^{2+}$ or $[M+3H]^{3+}$). Matches between the calculated molecular mass and the experimentally observed mass confirm that the peptide sequence sequence integrity and side-chain protection deprotections were successfully achieved during solid-phase peptide synthesis (SPPS).

Bacterial Endotoxin Testing and Biological Safety Metrics

For preclinical research applications—particularly cell culture assays and animal tissue models—the presence of bacterial endotoxins poses a severe confounding risk. Endotoxins, primarily lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria, trigger potent inflammatory and immune cascades that can skew metabolic, apoptotic, and viability endpoints.

Endotoxin testing is conducted using a quantitative Limulus Amebocyte Lysate (LAL) assay or recombinant Factor C assay. The COA reports endotoxin concentration expressed in Endotoxin Units per milligram (EU/mg). PX1 Research maintains strict endotoxin control thresholds, guaranteeing levels far below standard research thresholds (typically <0.05 EU/mg) to prevent non-specific macrophage activation or cellular toxicity in experimental setups.

Physical Appearance, Solubility, and Moisture Analysis

In addition to instrumental chromatography and spectrometry, physical properties provide crucial baseline metrics for lot consistency and handling stability. A comprehensive Adipotide COA documents physical appearance, typically describing the material as a uniform, lyophilized white to off-white cake or powder.

Residual moisture content is quantified using Karl Fischer titration or loss on drying (LOD) methodologies. Excessive residual water in lyophilized peptide cakes accelerates hydrolytic degradation during storage and reduces long-term shelf life. Acceptable COA standards mandate residual moisture levels below 5.0%. Evaluating solubility parameters in standard laboratory diluents, such as sterile bacteriostatic water or phosphate-buffered saline (PBS), confirms that the lyophilized matrix dissolves completely without precipitation or particulate formation.

Comparative Analysis: Adipotide Quality Protocols vs. Related Metabolic Research Peptides

When designing multi-target preclinical protocols evaluating targeted apoptosis, cellular energy expenditure, or metabolic signaling pathways, researchers frequently compare Adipotide with other metabolic and signaling compounds. Each peptide class presents unique chemical synthesis challenges and distinct COA profiles that reflect their underlying molecular structures.

For instance, while Adipotide is a complex conjugated peptidomimetic targeting endothelial prohibitin, non-peptidic or enzymatic metabolic modulators like AICAR operate through direct AMPK activation, requiring distinct HPLC solvent gradients for purity resolution. Similarly, small-molecule enzyme inhibitors such as 5-Amino-1MQ rely heavily on nuclear magnetic resonance (NMR) alongside mass spectrum verification. Meanwhile, central pathway modulators like Tesofensine demand rigorous chiral purity assessments. Maintaining rigorous analytical standards across all these target classes allows investigators to conduct side-by-side comparative studies with confidence in compound identity and activity.

Interpreting Lot-Specific Data for Laboratory Protocol Design

Integrating raw analytical data from a COA into daily laboratory workflows ensures precise concentration calculations and reproducible dosing protocols in preclinical models. Because peptide preparations contain small percentages of residual counter-ions (such as trifluoroacetate or acetate) and bound moisture, the net peptide content (molecular weight fraction attributable strictly to the peptide sequence) must be accounted for when preparing stock solutions.

Researchers analyzing data provided in our extensive PX1 research library utilize the exact purity percentage and net peptide content listed on the COA to adjust volumetric reconstitutions. For example, if a protocol requires an exact molar concentration for an in vitro prohibitin binding assay, using the net peptide factor derived from the lot COA prevents systematic errors in concentration-response curves.

PX1 Research Sourcing: USA Synthesis and ISO 17025 Laboratory Verification

PX1 Research enforces stringent quality control measures by synthesizing research peptides in state-of-the-art, GMP-compliant facilities within the USA. Every production lot undergoes independent analytical testing in ISO 17025 accredited laboratories using fully validated HPLC, MS, and LAL endotoxin methodologies.

To support high-throughput institutional research and recurring laboratory workflows, PX1 offers lot-matched documentation for individual orders as well as large-scale procurement through our wholesale institutional program. Orders ship directly from our centralized distribution facilities in California and Arizona, with same-day dispatch for orders finalized Monday through Friday prior to cutoff times.

Frequently Asked Questions

What specific testing parameters are included on an Adipotide COA from PX1 Research?

Every PX1 Research Adipotide COA includes lot-specific metrics: Reverse-Phase HPLC chromatograms verifying purity (≥98%), Mass Spectrometry (ESI-MS/MALDI) confirming molecular weight, quantitative LAL endotoxin levels (<0.05 EU/mg), physical appearance descriptions, and Karl Fischer moisture content analysis.

Why is endotoxin testing critical for Adipotide in cell culture and preclinical assays?

Endotoxins (lipopolysaccharides) provoke non-specific inflammatory signaling and cellular apoptosis via TLR4 pathways. In preclinical research evaluating targeted endothelial apoptosis, high endotoxin levels create false-positive toxicity results or confound cellular viability metrics.

What HPLC purity threshold is required for reproducible Adipotide research?

PX1 Research mandates a minimum threshold of ≥98.0% purity by RP-HPLC for all Adipotide lots. Lower purity compounds contain synthesis deletion fragments that can competitively block prohibitin receptors without inducing the desired apoptotic cascade, altering experimental outcomes.

How does Mass Spectrometry confirm the exact identity of Adipotide?

Mass Spectrometry calculates the mass-to-charge ratio ($m/z$) of ionized peptide molecules. Comparing the observed mass spectrum against Adipotide's theoretical monoisotopic mass (~2555.1 Da) confirms complete peptide chain assembly, accurate amino acid sequence, and complete side-chain deprotection.

How should lyophilized Adipotide be stored upon arrival to maintain COA-verified purity?

Lyophilized Adipotide should be stored at -20°C or -80°C in a manual defrost freezer protected from light and moisture. Proper storage maintains chemical stability and prevents hydrolytic cleavage or oxidation over extended laboratory storage periods.

Can institutional facilities request lot-specific COAs prior to bulk procurement?

Yes, PX1 Research provides lot-specific COAs for all research compounds upon request. Institutional buyers and primary investigators can review analytical data sheets prior to placing bulk orders through our laboratory sales department.

How does Adipotide compare analytically to metabolic compounds like 5-Amino-1MQ or AICAR?

While Adipotide is a complex targeted peptidomimetic analyzed primarily via RP-HPLC and ESI-MS, compounds like AICAR and 5-Amino-1MQ are smaller molecules requiring different chromatographic stationary phases and additional analytical verification like NMR spectral analysis.

What diluents are recommended for laboratory reconstitution of Adipotide?

For in vitro cellular assays and laboratory testing, Adipotide is typically reconstituted using sterile bacteriostatic water, sterile normal saline (0.9% NaCl), or standard laboratory buffers such as PBS, depending on specific assay compatibility.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.